Analysts expect over 2018 rising revenue Sartorius

Tomorrow the German Sartorius will publish its past quarters figures. Over the current book year the total revenue will be 1,69 billion euros (consensus estimates). This is slightly more than 2017's revenue of 1,57 billion euros.

Historical revenues and results Sartorius plus estimates 2018

The analysts expect for 2018 a net profit of 180 million euros. The majority of the analysts expects for this year a profit per share of 2,64 euros. Based on this the price/earnings-ratio is 50.

For this year most of the analysts expect a dividend of 0,65 cents per share. Thus the dividend yield equals 0,49 percent. The average dividend yield of the biotech companies equals a poor 0,5 percent.

Latest estimates around 111 euros

The latest 3 recommendations for the biotech company were provided by Nord Landesbank, M.M. Warburg & Co. and Kepler Capital Markets.

Sartorius's market capitalization is based on the number of outstanding shares around 4,52 billion euros. The Sartorius stock was the past 12 months quite unstable. Since last February the stock is even 41 percent higher. This year the stock price moved between 90 and 141 euro. Since 2008 the stock price is almost 4593 percent higher.

At 9.53 the stock trades 1,14 percent higher at 132 euros.

Historical stock prices Sartorius

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.